Ownership Profile
Ownership Profile
Top Holders
| Holder | Shares Held | % O/S | Share Change | Filing Date |
|---|---|---|---|---|
| Fidelity Management & Research Company LLC | 21,144,455 | 14.98 | 50,559 | 6/30/21 |
| The Vanguard Group, Inc. | 12,655,829 | 8.97 | 51,680 | 6/30/21 |
| T. Rowe Price Associates, Inc. | 12,258,827 | 8.69 | -321,229 | 6/30/21 |
| Bellevue Asset Management AG | 9,930,245 | 7.04 | 946,011 | 6/30/21 |
| ARK Investment Management LLC | 8,907,733 | 6.31 | 3,765,462 | 6/30/21 |
| ClearBridge Investments, LLC | 6,815,601 | 4.83 | -587,366 | 6/30/21 |
| BlackRock Institutional Trust Company, N.A. | 6,649,082 | 4.71 | -1,228,872 | 6/30/21 |
| Biogen Inc | 5,750,577 | 4.07 | -5,750,576 | 12/31/19 |
| State Street Global Advisors (US) | 3,230,951 | 2.29 | -178,620 | 6/30/21 |
| Camber Capital Management LP | 2,000,000 | 1.42 | 1,000,000 | 6/30/21 |
Top Holders: Mutual Funds
| Fund | Shares Held | % O/S | Share Change | Filing Date |
|---|---|---|---|---|
| ARK Genomic Revolution ETF | 8,808,020 | 6.24 | -217,315 | 8/31/21 |
| BB Biotech Fd | 8,166,962 | 5.79 | -32,951 | 3/31/21 |
| Fidelity Growth Company Fund | 7,945,631 | 5.63 | 18,517 | 7/31/21 |
| Vanguard Total Stock Market Index Fund | 3,788,897 | 2.68 | -7,025 | 8/31/21 |
| T. Rowe Price Mid-Cap Growth Fund | 3,712,000 | 2.63 | -38,000 | 6/30/21 |
| Vanguard Small-Cap Index Fund | 3,341,904 | 2.37 | 6,880 | 8/31/21 |
| ClearBridge Aggressive Growth Fund | 2,306,791 | 1.63 | -- | 6/30/21 |
| Vanguard Small-Cap Growth Index Fund | 2,116,067 | 1.50 | 6,912 | 8/31/21 |
| Vanguard Extended Market Index Fund | 2,033,467 | 1.44 | 2,181 | 8/31/21 |
| First Trust NYSE Arca Biotechnology Index Fund | 1,713,383 | 1.21 | 206,951 | 7/31/21 |
* Insider values reflect direct beneficial ownership.
Copyright Refinitiv